It is confirmed that long-term use of sleeping tablets taken by millions of patients has been related to a 50 per cent possibility of Alzheimer’s disease in the future, according to a latest study whose authors say unwanted use of the drugs is very dangerous for health concern.
The danger is mostly strong for long-term consumers of the commonly prescribed drugs, there is a proved evidence that benzodiazepine use enhances the possibility of Alzheimer’s disease and the researchers advise people should not be using the drugs for longer than three months.
On the other hand, other specialists said the results may reveal facts that people who are already in the early stages of Alzheimer’s are often treated for sleep problems and anxiety and this is confusing the findings, even if an increased risk of dementia has been identified in benzodiazepine users, the nature of this involvement whether causal or not, stays unclear.
However, these medicines would have been given to cure symptoms of insomnia and anxiety and it is possible that the person will suffer from the initial indications of unidentified Alzheimer’s disease, although the authors have tried to give precaution tips to prevent for this disease as far as was possible in their study.
The head of the Neurodegeneration Research Laboratory in Sydney, Dr Bryce Vissel, said physicians should more carefully examine the patients of anxiety, he further said dementia is a rising problem in Australia and the study highlighted a serious health concern problem when such high numbers of older and adults are using the sleeping drugs.
They compared 1796 cases of Alzheimer’s disease to consequences of 7184 healthy people of the young age and gender over a six-year window, the whole research shows that anxiety medication will directly affect the nervous system, memory power and brain cells.
The authors also said their findings are particularly significant because there are a very small number of medicines available to treat Alzheimer’s disease, with the help of this report doctors might change prescribing habits and give safe advises to decrease people’s risk of developing dementia.